Skip to main content
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.930
-0.310 (-7.31%)
At close: Jan 30, 2025, 4:00 PM
3.998
+0.068 (1.74%)
After-hours: Jan 30, 2025, 5:22 PM EST

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $3.86M in the quarter ending September 30, 2024, with 16.93% growth. This brings the company's revenue in the last twelve months to $14.58M, up 0.54% year-over-year. In the year 2023, Vivos Therapeutics had annual revenue of $13.80M, down -13.87%.

Revenue (ttm)
$14.58M
Revenue Growth
+0.54%
P/S Ratio
1.04
Revenue / Employee
$118,545
Employees
123
Market Cap
19.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 201911.39M7.60M200.43%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.95B
Revenue Rankings

VVOS News

More News